April 26, 2010 Dr. Regina Rabinovich Director of Infectious Disease Program Bill & Melinda Gates Foundation PO BOX 23350 Seattle, WA 98102 Dear, Dr. Rabinovich Attached…

1. 1 ‘‘SITUATION ANALYSIS OF RABIES IN NEPAL & RABIES RELATED PROGRAMME STRATEGIES IN NEPAL’’2/17/2013 A TERM PAPER PRESENTATION 2. 2Prepared bySAgun PAudelPresented…

Slide 1Evolutionary models: applications Examples from Clinical Virology Dr Gert van Zyl NHLS, Tygerberg and Stellenbosch University Slide 2 Case 1 Mystery illness causes…

Slide 1SUSTAINING LEPROSY CONTROL MEASURES IN THE PUBLIC HEALTH SYSTEM TO ENSURE QUALITY CARE Supported by ANESVAD Foundation, Spain implemented by ALERT INDIA, Mumbai, India…

Slide 1Copyright Feb. 2005 NHFA1 CODEX Slide 2 2 HEALTH FREEDOM PRINCIPLES Freedom of access for health-seekers Freedom to practice all healing methods Regulate by the least…

1. Hepatitis C Virus Casey McGrath BIO 360 2. Epidemiology Introduction to Hepatitis C Virus Immune response Novel drug therapies Conclusions Outline 3. Epidemiology Hepatitis…

1. JE surveillance in Sri Lanka country presentation for the 5th Bi-regional meeting on JE prevention and controlDr. Pushpa Ranjan Wijesinghe National Surveillance Focal…

Pneumococcal Disease Epidemiology, Drug resistance and prevention By.A.Arputha Selvaraj APMP IIM Calcutta Epidemiology Estimated Annual Disease Burden Worldwide Pneumococcal…

Vol. 41 No.1505 th – 11 th April 2014 This is the second in a series of three articles on theNationalStrategicPlanforDenguePreven- tion and Control. 4.SocialmobilizationandInter-sectoralco-…

Slide 1Predicting Outcomes of HCV Recurrence in Liver Transplants; Bilirubin as a Marker for Preservation Injury Joseph Park Advisor: Richard Gilroy, M.D. Kansas University…